Breaking News

Over a month ago Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
CDLX Cardlytics $22.95 0.23 (1.01%) , LYG Lloyds Banking $3.01 0.06 (2.04%) 09:26 10/04/18 10/04 09:26 10/04/18 09:26 Hot Stocks	Cardlytics announces multiyear contract renewal with Lloyds Bank » Cardlytics (CDLX)… Cardlytics (CDLX) announced a multi-year contract renewal with Lloyds Bank (LYG). On September 28, 2018, Cardlytics UK Limited, a wholly owned subsidiary of Cardlytics, Inc., renewed its Spending Rewards Agreement with Lloyds Bank Plc. Under the agreement, Cardlytics UK Limited will continue to provide Cardlytics Direct to Lloyds customers through December 31, 2020. CDLX Cardlytics $22.95 0.23 (1.01%) LYG Lloyds Banking $3.01 0.06 (2.04%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
CDLX Cardlytics $21.04 0.79 (3.90%) 04:55 09/10/18 09/10 04:55 09/10/18 04:55 Conference/Events	Cardlytics management to meet with SunTrust » Meeting to be held in New… Meeting to be held in New York on September 10 hosted by SunTrust. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	10 Sep
CDLX Cardlytics $20.71 0.315 (1.54%) 08:55 09/05/18 09/05 08:55 09/05/18 08:55 Conference/Events	Cardlytics management to meet with SunTrust » Meeting to be held in New… Meeting to be held in New York on September 10 hosted by SunTrust. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	10 Sep

Over a quarter ago
CDLX Cardlytics $20.33 0.22 (1.09%) 16:09 08/14/18 08/14 16:09 08/14/18 16:09 Earnings	Cardlytics reports Q2 EPS (21c), consensus (53c) » Reports Q2 revenue… Reports Q2 revenue $35.6M, consensus $34.84M. Adjusted EBITDA was a loss of $(2.2) million compared to a loss of $(2.8) million in the second quarter of 2017. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	14 Aug
CDLX Cardlytics $20.12 -0.32 (-1.57%) 16:28 05/10/18 05/10 16:28 05/10/18 16:28 Earnings	Cardlytics reports Q1 EPS (35c), consensus (62c) » Reports Q1 revenue… Reports Q1 revenue $32.7M, consensus $29.81M. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	10 May

BDX Becton Dickinson $218.01 0.735 (0.34%) , CDLX Cardlytics $16.80 -0.5 (-2.89%) … 10:39 03/06/18 03/06 10:39 03/06/18 10:39 Initiation	On The Fly: Top five analyst initiations » Catch up on today's… Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Becton Dickinson (BDX) initiated with a Market Perform at BMO Capital. 2. Cardlytics (CDLX) initiated with a Buy at SunTrust, an Overweight at JPMorgan and KeyBanc, a Neutral at BofA/Merrill, and an Outperform at Wells Fargo. 3. iRhythm (IRTC) initiated with an Outperform at BMO Capital. 4. Genocea (GNCA) initiated with an Overweight at Cantor Fitzgerald. 5. Domino's Pizza (DPZ) initiated with an Outperform at Baird. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here. BDX Becton Dickinson $218.01 0.735 (0.34%) CDLX Cardlytics $16.80 -0.5 (-2.89%) IRTC iRhythm $63.66 -0.57 (-0.89%) GNCA Genocea $1.03 0.02 (1.98%) DPZ Domino's Pizza $221.25 1.64 (0.75%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Mar 19 Mar 30 May
CDLX Cardlytics $16.80 -0.5 (-2.89%) , WFC Wells Fargo $57.59 0.18 (0.31%) 07:14 03/06/18 03/06 07:14 03/06/18 07:14 Initiation	Cardlytics, Wells Fargo initiated at SunTrust » Cardlytics initiated with… Cardlytics initiated with a Buy at SunTrust. SunTrust analyst Youssef Squali initiated Cardlytics (CDLX) with a Buy rating and a price target of $25. Squali contends that the discount with which this "leader in the $11B native ad bank market trade" should close once investors become familiar with its "limited inventory, large partnerships and lack of easily identifiable publicly-traded comps", looking beyond the company's longer sales cycle. The analyst also points to Cardlytics pilot partnership with Wells Fargo (WFC) in first party data collection, which could roll out nationwide in 2019 and create more significant revenue growth. CDLX Cardlytics $16.80 -0.5 (-2.89%) WFC Wells Fargo $57.59 0.18 (0.31%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	06 Mar 07 Mar 12 Mar 15 Mar 19 Mar 30 May
CDLX Cardlytics $16.80 -0.5 (-2.89%) 06:38 03/06/18 03/06 06:38 03/06/18 06:38 Initiation	Cardlytics initiated at JPMorgan » Cardlytics initiated with… Cardlytics initiated with an Overweight at JPMorgan. JPMorgan analyst Doug Anmuth started Cardlytics with an Overweight rating and $23 price target. The company has "valuable purchase intelligence" which "closes the loop" for advertisers and differentiates its from other marketing platforms, Anmuth tells investors in a research note. He expects the Cardlytics' revenue growth to accelerate in 2018 and 2019. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	19 Mar
CDLX Cardlytics $16.80 -0.5 (-2.89%) 06:16 03/06/18 03/06 06:16 03/06/18 06:16 Initiation	Cardlytics initiated at BofA/Merrill » Cardlytics initiated with… Cardlytics initiated with a Neutral at BofA/Merrill. BofA/Merrill analyst Nat Schindler initiated Cardlytics with a Neutral and $19 price target saying he is cautious on client concentration and limited pricing leverage. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	19 Mar
CDLX Cardlytics $16.80 -0.5 (-2.89%) 05:15 03/06/18 03/06 05:15 03/06/18 05:15 Initiation	Cardlytics initiated at Wells Fargo » Cardlytics initiated with… Cardlytics initiated with an Outperform at Wells Fargo. Wells Fargo analyst Timothy Willi started Cardlytics with an Outperform rating and $22 price target. The analyst views the company as a secular play on payment data monetization, digital banking and digital advertising. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	19 Mar

On The Fly

News and insights, exclusive to thefly.com

08:57	Fly Intel: Pre-market Movers»
07:32	U.S. stocks pointed to higher open despite UK's Brexit chaos»
20:25	Notable companies reporting before tomorrow's open»
18:54	Fly Intel: After Hours Movers»
15:12	Neurocrine slides as Ingrezza serious cases count updated in FDA system»

View all On The Fly Stories »

Upcoming
Events (10)

AMAG ...	London Healthcare Conference
	Macro Economic Outlook Conference
	West Coast Internet Bus Tour
AVHI ...	5th Annual Housing Conference
	Indonesia Conference
WIFI ...	9th Annual Craig-Hallum Alpha Select Conference
NVS ...	2018 ACAAI Meeting
AINC ...	Southwest Ideas Conference
	21st India Forum
	Japan Corporate Day

View all of today’s events »

Today’s
Syndicate (10)

BCSF	IPO
CNTX	IPO
WEI	IPO
ED	Secondary
NGHC	Secondary
VICI	Secondary
AGNC	Spot Secondary
EYE	Spot Secondary
HSDT	Spot Secondary
KREF	Spot Secondary

View this week’s syndicate »

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial